Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by topseekeron Jul 20, 2020 5:46pm
282 Views
Post# 31292925

The Pressure is Building

The Pressure is Building Good Evening All,

 As can be seen, the pressures in the USA to combat covid 19, is going through the roof. Algernon appears to be in the right spot with the right product at the right time.. Starting in Miami may turn into the first showcase of their product success. 

 Going to be very interesting for All us Longs in the weeks/months ahead.

U.S. Cases Rise 1.3%; Florida to Speed Up Testing: Virus Update

Updated on

A coronavirus vaccine the University of Oxford is developing with AstraZeneca Plc showed promising results in early human testing, a sign of progress in the high-stakes pursuit of a shot to defeat the pathogen. Pfizer Inc. and BioNTech SE also reported positive data from a vaccine trial.

 
 

New York Governor Andrew Cuomo threatened to close down all bars and restaurants if large street gatherings continue and his social distance and mask regulations aren’t enforced. California reported slowing growth in virus hospitalizations, while Florida said it aims to speed up testing for people with symptoms.




 Best wishes to All, good health,

 Good Fortune,

 Sincerely,

 Topseeker

<< Previous
Bullboard Posts
Next >>